Evidence map›Paper›PMID 35528922›Full record

ArticleRSC advances2019

Carbon nanoparticle-protected RNA aptasensor for amplified fluorescent determination of theophylline in serum based on nuclease-aided signal amplification.

Xiaoyu Gong, Chi Yu, Yichang Zhang, Yuan Sun, Lin Ye, Juan Li

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaoyu GongLonggang District People's Hospital of Shenzhen Shenzhen Guangdong 518172 P. R. China.
Chi YuHubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine Wuhan Hubei 430065 P. R. China lz198207@126.com.
Yichang ZhangHubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine Wuhan Hubei 430065 P. R. China lz198207@126.com.
Yuan SunHubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine Wuhan Hubei 430065 P. R. China lz198207@126.com.
Lin YeDepartment of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei 430022 P. R. China ylwhuhhust@hust.edu.cn.
Juan LiHubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine Wuhan Hubei 430065 P. R. China lz198207@126.com.ORCID https://orcid.org/0000-0002-9838-0990
Hubei University of Chinese Medicine · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A carbon nanoparticle (CNP) and Cryonase-aided method that realizes the amplified fluorescent detection of theophylline was proposed. The amplification technique exploits distinct binding affinities of CNP towards the FAM-labeled theophylline RNA aptamer (aptasensor) and aptasensor/theophylline complex as well as the protection effect of CNP for absorbed aptasensor from enzymatic digestion by Cryonase. Upon the addition of theophylline, it forms an aptasensor/theophylline complex with a fluorescent dye-tagged aptasensor that is initially absorbed and quenched by CNP. The nuclease activity of Cryonase towards detached aptasensor probes is then activated, leading to efficient cleavage of aptasensor probes and separation of the fluorescent dye from the CNP surface. Theophylline that has been liberated can launch another reaction cycle, which ensures the sensitivity enhancement. A detection limit is achieved as high as 6.3 nM, which is 400-fold better than traditional strategies. The proposed sensing system also provides desired selectivity even in serum samples. The assay is simple, sensitive, selective, and universal, and has great promise for the design and application of aptasensors in the biological, chemical, and biomedical fields.

Identifiers

PMID35528922
PMCPMC9073590
OpenAlexW2981503738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.